Cost of drugs is the threat to Obamacare

The cost of drugs is the driving force behind the accelerating price of health coverage and threatens the future of Obamacare.

The latest example is the 500 percent increase increase in cost of the EpiPen allergy drug while the the CEO, Heather Bresch, annual pay soared to $18.9 million.

It is no accident that "Pharma CEOS are paid 71 percent more than median in S&P 500" according to USA Today. The government can't negotiate for generic drugs in Medicare D, drug companies are protected for 7 years and then buy their competition and keep charging exorbitant prices. And, meanwhile prices to the consumers, most on fixed incomes, continue to climb.

Congress, happy to swim in lobbyist money, do nothing as usual and consumers wonder why drugs are much less expensive in Canada and Europe. It's simple - the rich have rigged the system to take advantage of the average consumer once again for their own gain.

Tom Minnerick

Elgin